Xuewei Xie Selected Research

Xuewei Xie Research Topics

25	Stroke (Strokes) 02/2024 - 01/2017
20	Ischemic Stroke 02/2024 - 01/2019
14	Transient Ischemic Attack 02/2024 - 01/2017
10	Hemorrhage 02/2024 - 12/2021
2	Hypertension (High Blood Pressure) 01/2022 - 01/2019
2	Atrial Fibrillation 04/2019 - 10/2017
1	Pathologic Constriction (Stenosis) 11/2023
1	Obesity 10/2023
1	Atherosclerosis 01/2023
1	Diabetes Mellitus 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020

17	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2024 - 01/2017
16	Clopidogrel (Plavix)FDA Link 02/2024 - 01/2017
16	TicagrelorIBA 02/2024 - 01/2021
15	Cytochrome P-450 CYP2C19IBA 02/2024 - 01/2021
9	Antihypertensive Agents (Antihypertensives)IBA 10/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
2	C-Reactive ProteinIBA 11/2022 - 11/2020
1	HomocysteineIBA 02/2024
1	CholesterolIBA 01/2024
1	danaparoid (Orgaran)FDA Link 01/2023
1	indobufenIBA 01/2023
1	Colchicine FDA LinkGeneric 11/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022
1	Streptokinase FDA Link 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	Cystatin CIBA 01/2021
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020
1	ORALIT (ORS)IBA 01/2019

16	Therapeutics 02/2024 - 01/2017
7	Secondary Prevention 02/2024 - 10/2017